Published in Eur J Immunol on March 01, 2000
Inborn errors of human JAKs and STATs. Immunity (2012) 1.90
IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo. Blood (2011) 1.28
Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J Virol (2006) 1.20
Severe combined immunodeficiencies (SCID). Clin Exp Immunol (2000) 1.17
Update on Janus kinase antagonists in inflammatory bowel disease. Gastroenterol Clin North Am (2014) 1.05
Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy. Mol Ther (2010) 0.98
Intravenous injection of a foamy virus vector to correct canine SCID-X1. Blood (2014) 0.89
From murine to human nude/SCID: the thymus, T-cell development and the missing link. Clin Dev Immunol (2012) 0.89
Severe combined immunodeficiency--molecular pathogenesis and diagnosis. Arch Dis Child (2001) 0.85
Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3δ deficiency. Bone Marrow Transplant (2016) 0.75
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency. J Clin Immunol (2015) 0.75
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet (2000) 3.00
Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol (1998) 2.97
Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet (1995) 2.29
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant (2009) 2.00
Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol (1998) 1.87
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant (2007) 1.72
Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr (2001) 1.67
Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet (1996) 1.67
Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse. Lancet (1992) 1.56
Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood (2000) 1.53
Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer (2005) 1.50
B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J Biol Chem (1994) 1.48
Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol (2008) 1.47
Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum Mol Genet (1994) 1.44
Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant (2003) 1.34
The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant (2008) 1.32
Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant (2009) 1.28
Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant (2006) 1.28
Polarized expression of bone morphogenetic protein-4 in the human aorta-gonad-mesonephros region. Blood (2000) 1.25
Characterization of the murine heat-stable antigen: an hematolymphoid differentiation antigen defined by the J11d, M1/69 and B2A2 antibodies. Eur J Immunol (1990) 1.21
Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur J Immunol (1994) 1.20
BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res (1996) 1.20
Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J Immunol (2001) 1.17
Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum Gene Ther (1998) 1.16
Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol (2011) 1.12
Progress and prospects: gene therapy clinical trials (part 1). Gene Ther (2007) 1.09
Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol (1998) 1.06
Adeno-associated virus gene transfer to mouse retina. Hum Gene Ther (1998) 1.06
The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J Exp Med (1995) 1.06
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2007) 1.05
Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression. Eur J Immunol (2000) 1.05
Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplant (2012) 1.04
The murine heat-stable antigen: a differentiation antigen expressed in both the hematolymphoid and neural cell lineages. Eur J Immunol (1991) 1.04
Progress and prospects: gene therapy for inherited immunodeficiencies. Gene Ther (2009) 1.03
Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency. Clin Exp Immunol (2007) 1.03
p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox. Blood (1994) 1.03
BTKbase: a database of XLA-causing mutations. International Study Group. Immunol Today (1995) 1.03
Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation. Am J Obstet Gynecol (2000) 1.02
Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics (1992) 1.02
Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood (2001) 1.01
Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant (2007) 1.01
In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol (2001) 1.01
Conservative management of pneumatosis intestinalis and pneumoperitoneum following bone-marrow transplantation. Pediatr Surg Int (2002) 1.01
Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes. J Biol Chem (1981) 1.00
Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J Clin Pathol (2004) 1.00
CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today (1996) 1.00
Detailed characterization of the human aorta-gonad-mesonephros region reveals morphological polarity resembling a hematopoietic stromal layer. Dev Dyn (1999) 0.98
Resolution of peanut allergy following bone marrow transplantation for primary immunodeficiency. Allergy (2005) 0.96
Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis. Biochem J (1996) 0.96
Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency. J Clin Immunol (2012) 0.94
Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood (2000) 0.93
Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med (2000) 0.93
Physical mapping identifies DXS265 as a useful genetic marker for carrier detection and prenatal diagnosis of X-linked agammaglobulinemia. Hum Genet (1993) 0.93
A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther (2009) 0.93
Topical cidofovir for severe molluscum contagiosum. Lancet (1999) 0.93
Clathrin-coated vesicles purified from a human B lymphocyte cell line contain newly synthesized glycoproteins. J Biol Chem (1983) 0.92
The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto-phosphorylated in vitro. Eur J Immunol (1999) 0.92
The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked. Eur J Immunol (1995) 0.92
Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplant (2005) 0.91
Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J Immunol (1996) 0.91
High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H. Hum Gene Ther (1999) 0.89
Carrier determination for X-linked agammaglobulinemia using X inactivation analysis of purified B cells. J Immunol Methods (1993) 0.88
The effect of a metaphylactic treatment with diclazuril (Vecoxan) on the oocyst excretion and growth performance of calves exposed to a natural Eimeria infection. Vet Parasitol (2007) 0.87
Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat (1996) 0.87
Current progress on gene therapy for primary immunodeficiencies. Gene Ther (2013) 0.87
Severe combined immunodeficiency with abnormalities in expression of the common leucocyte antigen, CD45. Arch Dis Child (1997) 0.87
Is Wiskott--Aldrich syndrome a cell trafficking disorder? Immunol Today (1998) 0.87
T cell depletion in paediatric stem cell transplantation. Clin Exp Immunol (2013) 0.86
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol (2004) 0.86
Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol (2004) 0.86
X-linked lymphoproliferative disease: three atypical cases. Clin Exp Immunol (2001) 0.86
X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox. Blood (1993) 0.86
Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids. Gene Ther (2004) 0.85
Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant (1998) 0.84
A defined window for efficient gene marking of severe combined immunodeficient-repopulating cells using a gibbon ape leukemia virus-pseudotyped retroviral vector. Hum Gene Ther (2000) 0.84
Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Clin Exp Immunol (1998) 0.84
Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12. Br J Cancer (2003) 0.84
Pulsed-field gel electrophoresis and radiation hybrid mapping analyses enable the ordering of eleven DNA loci in Xq22. Genomics (1993) 0.84
Effect of tunicamycin and cycloheximide on the secretion of acid hydrolases from I-cell cultured fibroblasts. Biochem J (1980) 0.83
Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays. J Immunol Methods (1992) 0.83
Gene transfer to primary chronic granulomatous disease monocytes. Lancet (1995) 0.83
Mutation analysis in Bruton's tyrosine kinase, the X-linked agammaglobulinaemia gene, including identification of an insertional hotspot. Hum Mol Genet (1995) 0.82
Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12. Br J Cancer (2007) 0.82
Activation of T cell antigen receptor alpha- and beta-chain genes in the thymus: implications for the lineages of developing cortical thymocytes. J Immunol (1986) 0.82
The Wiskott-Aldrich syndrome. Clin Exp Immunol (2000) 0.82
Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells. Blood (1991) 0.82
T cell transduction and suicide with an enhanced mutant thymidine kinase. Gene Ther (2002) 0.82
Social outcome in children treated by haematopoietic cell transplant for congenital immunodeficiency. Bone Marrow Transplant (2011) 0.81
X linked agammaglobulinaemia with a 'leaky' phenotype. Arch Dis Child (1996) 0.81